Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

are typically adult skin or blood cells that have been reprogrammed in a lab to become like embryonic stem cells, which are ...

Japan 2 Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan To make decisions for treatment, adult T-cell leukemia ...

But researchers are challenging this idea with the startling discovery of adult cells that ... replicate the findings, such cells might be used in stem cell therapy, says Deepak Srivastava ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.

Autoimmune diseases occur when the body's immune system mistakenly attacks healthy cells, creating chronic inflammation and long-term damage. Conventional treatment simply targets symptoms ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published in Nature this week, investigate the use of cells derived from human ...

Stem cell treatment uses reprogrammed cells to repair ... were conducted between the years 2021 and 2023 in four men older than the age of adult, two of whom were more than 60 years old.

Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...